Achilles Tendinopathy; the Effect of Shockwave Treatment
Comparison of Two Treatment Methods for Achilles Tendon Pain With a Focus on Pain, Function, Vascular Ingrowth, Immune Cell Response, and Cell Composition
2 other identifiers
interventional
200
0 countries
N/A
Brief Summary
BACKGROUND Achilles tendinopathy-pain in the Achilles tendon-is a common and often long-lasting condition that limits physical activity and performance, and also affects work capacity and quality of life. The pain is localized either to the mid- portion of the tendon or at its insertion into the calcaneus. Although individually tailored exercise is the first-line treatment, symptoms persist in many patients, highlighting the need for adjunctive therapies. AIM This interdisciplinary and innovative research project aims to evaluate the effect of shockwave therapy in Achilles tendinopathy, both in cases where the pain is located in the mid-portion of the tendon and where it is situated at the tendon's insertion. In addition to assessing effects on pain and function, the study will examine the impact on calcifications, neovascularization (evaluated via Doppler ultrasound), and-uniquely-systemic immunological effects, with a focus on NK cells in the blood, an area that remains largely unexplored. METHOD This is a randomized controlled trial (RCT) with four arms, including 200 patients divided into two groups based on pain location. Half of the participants will receive adjunctive shockwave therapy in six sessions, in addition to exercise following the protocol by Silbernagel et al. The primary outcome measure is self-reported pain assessed using the Numeric Rating Scale (NRS) 0-10 at 12 months. Secondary outcomes include function, assessed through patient-reported outcomes (Victorian Institute of Sport Assessment-Achilles Swedish version, VISA-AS), calf muscle strength and endurance, and jumping ability using a validated test battery. Neovascularization and tendon cross-sectional area will be evaluated using ultrasound/Doppler. In a sub-cohort, immune cell composition in blood will be analyzed using flow cytometry before and after treatment. For patients undergoing surgery, tissue samples will also be collected for cellular composition analysis. SIGNIFICANCE This project has the potential to improve treatment strategies, reduce the need for surgery, and generate entirely new knowledge about the relationship between local tissue pathology and systemic immune responses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
Study Completion
Last participant's last visit for all outcomes
December 31, 2031
July 6, 2026
June 1, 2026
3.3 years
June 25, 2026
July 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in self-reported pain from baseline to 12 months after treatment start
Zero is equivalent to no pain and 10 indicates the worst possible pain.
At baseline and after 12 months after enrollment
Secondary Outcomes (12)
Change in self-reported pain 3 and 6 months after treatment start
At baseline and after 3 and 6 months after enrollment
Rate of blood vessels in the Achilles tendon
At baseline and after 3, 6, and 12 month
Achilles Tendon cross-sectional area
At baseline and after 3, 6 and 12 months
Physical Activity Scale (PAS)
At baseline and after 3,6 and 12 months
VISA-AS
At baseline and after 3, 6 and 12 months
- +7 more secondary outcomes
Other Outcomes (1)
Blood samples will be collected to assess changes in immune cell composition, focusing on NK and CD8+ T cells.
At baseline and after 4-6 weeks
Study Arms (4)
Achilles Tendinopathy, exercise therapy and additional treatment with shockwave
EXPERIMENTALPatients with Achilles Tendinopathy receiving exercise therapy with regular follow-ups and additional treatment with shockwave.
Achilles Tendinopathy, exercise therapy
ACTIVE COMPARATORPatients with Achilles Tendinopathy receiving exercise therapy with regular follow-ups
Insertional Achilles Tendinopathy, exercise therapy and additional treatment with shockwave
EXPERIMENTALPatients with Insertional Achilles Tendinopathy receiving exercise therapy with regular follow-ups and additional treatment with shockwave.
Insertional Achilles Tendinopathy, exercise therapy
ACTIVE COMPARATORPatients with Insertional Achilles Tendinopathy receiving exercise therapy with regular follow-ups
Interventions
Shockwave: 5-6 treatments with radial shockwave, 10 bar, 2000-4000 pulses as an additional treatment to individually tailored exercises.
Individually tailored exercises
Eligibility Criteria
You may qualify if:
- Women and men over 18 years of age who seek care for load-related pain in the midportion of the Achilles tendon or at the Achilles tendon insertion at a Physiotherapy Clinic in Primary Care, at the Physiotherapy Department at Sahlgrenska University Hospital/Mölndal, or at the Orthopedic Department at Sahlgrenska University Hospital/Mölndal.
- Symptoms must have been present for one month or longer.
- Symptoms may be present in one or both Achilles tendons.
You may not qualify if:
- Unwillingness to receive shockwave therapy.
- Previous shockwave therapy for Achilles tendon pain within the past year.
- Neurological disease, significant cardiac conditions, increased bleeding tendency, treatment with anticoagulant medication, pregnancy, or presence of a tumor in the foot.
- Corticosteroid injection in the foot within the past six months.
- Reduced sensation, acute inflammation, or any wound around the heel.
- Inability to understand or speak Swedish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Göteborg Universitycollaborator
- Vastra Gotaland Regionlead
Related Publications (24)
Silbernagel KG, Thomee R, Karlsson J. Cross-cultural adaptation of the VISA-A questionnaire, an index of clinical severity for patients with Achilles tendinopathy, with reliability, validity and structure evaluations. BMC Musculoskelet Disord. 2005 Mar 6;6:12. doi: 10.1186/1471-2474-6-12.
PMID: 15748297BACKGROUNDSilbernagel KG, Gustavsson A, Thomee R, Karlsson J. Evaluation of lower leg function in patients with Achilles tendinopathy. Knee Surg Sports Traumatol Arthrosc. 2006 Nov;14(11):1207-17. doi: 10.1007/s00167-006-0150-6. Epub 2006 Jul 21.
PMID: 16858560BACKGROUNDJonsson P, Alfredson H, Sunding K, Fahlstrom M, Cook J. New regimen for eccentric calf-muscle training in patients with chronic insertional Achilles tendinopathy: results of a pilot study. Br J Sports Med. 2008 Sep;42(9):746-9. doi: 10.1136/bjsm.2007.039545. Epub 2008 Jan 9.
PMID: 18184750BACKGROUNDFarrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9.
PMID: 11690728BACKGROUNDSantamato A, Beatrice R, Micello MF, Fortunato F, Panza F, Bristogiannis C, Cleopazzo E, Macarini L, Picelli A, Baricich A, Ranieri M. Power Doppler Ultrasound Findings before and after Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Pilot Study on Pain Reduction and Neovascularization Effect. Ultrasound Med Biol. 2019 May;45(5):1316-1323. doi: 10.1016/j.ultrasmedbio.2018.12.009. Epub 2019 Feb 8.
PMID: 30739723BACKGROUNDCheng Y, Zhang J, Cai Y. Utility of Ultrasonography in Assessing the Effectiveness of Extracorporeal Shock Wave Therapy in Insertional Achilles Tendinopathy. Biomed Res Int. 2016;2016:2580969. doi: 10.1155/2016/2580969. Epub 2016 Nov 28.
PMID: 28004000BACKGROUNDGatz M, Schweda S, Betsch M, Dirrichs T, de la Fuente M, Reinhardt N, Quack V. Line- and Point-Focused Extracorporeal Shock Wave Therapy for Achilles Tendinopathy: A Placebo-Controlled RCT Study. Sports Health. 2021 Sep-Oct;13(5):511-518. doi: 10.1177/1941738121991791. Epub 2021 Feb 13.
PMID: 33586526BACKGROUNDCharles R, Fang L, Zhu R, Wang J. The effectiveness of shockwave therapy on patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis: a systematic review and meta-analysis. Front Immunol. 2023 Aug 16;14:1193835. doi: 10.3389/fimmu.2023.1193835. eCollection 2023.
PMID: 37662911BACKGROUNDFeeney KM. The Effectiveness of Extracorporeal Shockwave Therapy for Midportion Achilles Tendinopathy: A Systematic Review. Cureus. 2022 Jul 18;14(7):e26960. doi: 10.7759/cureus.26960. eCollection 2022 Jul.
PMID: 35989757BACKGROUNDPaantjens MA, Helmhout PH, Backx FJG, van Etten-Jamaludin FS, Bakker EWP. Extracorporeal Shockwave Therapy for Mid-portion and Insertional Achilles Tendinopathy: A Systematic Review of Randomized Controlled Trials. Sports Med Open. 2022 May 13;8(1):68. doi: 10.1186/s40798-022-00456-5.
PMID: 35552903BACKGROUNDStania M, Mala J, Chmielewska D. The Efficacy of Extracorporeal Shock Wave Therapy as a Monotherapy for Achilles Tendinopathy: A Systematic Review and Meta-Analysis. J Chiropr Med. 2023 Dec;22(4):294-301. doi: 10.1016/j.jcm.2023.04.003. Epub 2023 Jun 14.
PMID: 38205224BACKGROUNDPinitkwamdee S, Laohajaroensombat S, Orapin J, Woratanarat P. Effectiveness of Extracorporeal Shockwave Therapy in the Treatment of Chronic Insertional Achilles Tendinopathy. Foot Ankle Int. 2020 Apr;41(4):403-410. doi: 10.1177/1071100719898461. Epub 2020 Jan 10.
PMID: 31924120BACKGROUNDMansur NSB, Matsunaga FT, Carrazzone OL, Schiefer Dos Santos B, Nunes CG, Aoyama BT, Dias Dos Santos PR, Faloppa F, Tamaoki MJS. Shockwave Therapy Plus Eccentric Exercises Versus Isolated Eccentric Exercises for Achilles Insertional Tendinopathy: A Double-Blinded Randomized Clinical Trial. J Bone Joint Surg Am. 2021 Jul 21;103(14):1295-1302. doi: 10.2106/JBJS.20.01826.
PMID: 34029235BACKGROUNDButler JJ, DeClouette B, Azam MT, Walls RC, Jejelava G, Zheng D, Jia N, Kennedy JG. Outcomes After Extracorporeal Shockwave Therapy for Chronic Noninsertional Achilles Tendinopathy Compared With Chronic Insertional Achilles Tendinopathy: A Retrospective Review. Orthop J Sports Med. 2024 Sep 4;12(9):23259671241265330. doi: 10.1177/23259671241265330. eCollection 2024 Sep.
PMID: 39247530BACKGROUNDAbdelkader NA, Helmy MNK, Fayaz NA, Saweeres ESB. Short- and Intermediate-Term Results of Extracorporeal Shockwave Therapy for Noninsertional Achilles Tendinopathy. Foot Ankle Int. 2021 Jun;42(6):788-797. doi: 10.1177/1071100720982613. Epub 2021 Jan 15.
PMID: 33451253BACKGROUNDRompe JD, Furia J, Maffulli N. Eccentric loading compared with shock wave treatment for chronic insertional achilles tendinopathy. A randomized, controlled trial. J Bone Joint Surg Am. 2008 Jan;90(1):52-61. doi: 10.2106/JBJS.F.01494.
PMID: 18171957BACKGROUNDRompe JD, Furia J, Maffulli N. Eccentric loading versus eccentric loading plus shock-wave treatment for midportion achilles tendinopathy: a randomized controlled trial. Am J Sports Med. 2009 Mar;37(3):463-70. doi: 10.1177/0363546508326983. Epub 2008 Dec 15.
PMID: 19088057BACKGROUNDBeyer R, Kongsgaard M, Hougs Kjaer B, Ohlenschlaeger T, Kjaer M, Magnusson SP. Heavy Slow Resistance Versus Eccentric Training as Treatment for Achilles Tendinopathy: A Randomized Controlled Trial. Am J Sports Med. 2015 Jul;43(7):1704-11. doi: 10.1177/0363546515584760. Epub 2015 May 27.
PMID: 26018970BACKGROUNDSilbernagel KG, Thomee R, Thomee P, Karlsson J. Eccentric overload training for patients with chronic Achilles tendon pain--a randomised controlled study with reliability testing of the evaluation methods. Scand J Med Sci Sports. 2001 Aug;11(4):197-206. doi: 10.1034/j.1600-0838.2001.110402.x.
PMID: 11476424BACKGROUNDAlfredson H, Pietila T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998 May-Jun;26(3):360-6. doi: 10.1177/03635465980260030301.
PMID: 9617396BACKGROUNDVerges J, Martinez N, Pascual A, Bibas M, Santina M, Rodas G. Psychosocial and individual factors affecting Quality of Life (QoL) in patients suffering from Achilles tendinopathy: a systematic review. BMC Musculoskelet Disord. 2022 Dec 21;23(1):1114. doi: 10.1186/s12891-022-06090-2.
PMID: 36544133BACKGROUNDKenyon M, Driver P, Mallows A, Stephens G, Bryant M, Al Dawoud M, O'Neill S. Characteristics of patients seeking national health service (NHS) care for Achilles tendinopathy: A service evaluation of 573 patients. Musculoskelet Sci Pract. 2024 Nov;74:103156. doi: 10.1016/j.msksp.2024.103156. Epub 2024 Sep 4.
PMID: 39270530BACKGROUNDde Jonge S, van den Berg C, de Vos RJ, van der Heide HJ, Weir A, Verhaar JA, Bierma-Zeinstra SM, Tol JL. Incidence of midportion Achilles tendinopathy in the general population. Br J Sports Med. 2011 Oct;45(13):1026-8. doi: 10.1136/bjsports-2011-090342.
PMID: 21926076BACKGROUNDMalliaras P, Gravare Silbernagel K, de Vos RJ, Bourke J, Sancho I, Hanlon SL, Agergaard AS, Bahr R, Bittencourt NFN, Bordalo M, Brorsson A, Tzortziou Brown V, Cardoso T, Child S, Chimenti RL, Cowley E, D'Hooghe P, Derman W, Finnoff JT, Fu SN, Halstead J, Hamilton B, Nilsson-Helander KM, Holmich P, Houghton J, James AM, Kulig K, Lau A, Ling S, Maffulli N, Masci L, Mayes S, Mc Auliffe S, McCrum C, Morrissey D, Munteanu SE, Murphy MC, Newsham-West R, O'Neill S, Padhiar N, Papadopoulou T, Rees JD, Rio EK, Ruffino D, Scott A, Speirs S, Sun Y, Thorborg K, Trease L, Verhaar JAN, Wezenbeek E, White S, Zellers JA, Zhang S, Korakakis V, Vicenzino B. Diagnostic domains, differential diagnosis and conditions requiring further medical attention that are considered important in the assessment for Achilles tendinopathy: a Delphi consensus study. Br J Sports Med. 2025 Jun 18;59(13):891-901. doi: 10.1136/bjsports-2024-109185.
PMID: 40240126BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 6, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2031
Last Updated
July 6, 2026
Record last verified: 2026-06